By the end of March, the agency could approve multiple “national priority” voucher winners, as well as a gene therapy it ...

After a tumultuous year, experts call for stability while anticipating the first fruits of policies intended to expedite ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

From nuclear power to immigration to layoffs, here are some attempts to guess the big business stories of the next 12 months.

As 2026 kicks in, we take a quick look back on 2025 – another bearish year for ASX healthcare. Australia’s leading analysts ...

The 'forever layoffs' era hits a recession trigger as corporates sack 1.1 million workers through November Passenger who died on cruise ship was served 33 drinks, lawsuit claims Trump admin is 'trying ...

The FDA said it cannot approve the application in its present form for the treatment of wet age-related macular degeneration.

From Robert F. Kennedy Jr.’s confirmation as HHS secretary to the resignation of the FDA’s top drug regulator, HHS saw several leadership transitions in 2025. Beyond leadership, HHS announced plans in ...

A personal reflection on the promise and limits of CAR T therapy—its breakthroughs, failures, scientific bottlenecks, and what must change to truly save more lives.

Best legal steroids for Body Building and Muscle Building from Wolfson Brands, legal steroids that really work for muscle ...

Potential blockbusters and root-cause treatments from Eli Lilly, Merck, Takeda and others could get a regulatory nod this ...

He has also promoted controversial views on vaccines, including removing the Centers for Disease Control and Prevention's ...